Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1)

Diagnostic Cytopathology

Volumn 41, Issue 1, 2013, Pages 41-46

  Chao, Tai Kuang ^a   Ke, Feng Yi ^a   Liao, Yu Ping ^b   Wang, Hui Chen ^a   Yu, Cheng Ping ^a   Lai, Hung Cheng ^a,b  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

ASC H; atypical squamous cells of undetermined significance (ASCUS); cervix; epigenetics; methylation

Indexed keywords

ADULT; ARTICLE; ATYPICAL SQUAMOUS CELLS OF UNDETERMINED SIGNIFICANCE; CANCER CYTODIAGNOSIS; COLPOSCOPE; COLPOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DNA METHYLATION; ENDOSCOPIC BIOPSY; FEMALE; FOLLOW UP; GENE; HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESION; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAIRED BOXED GENE 1; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DISEASE; WART VIRUS;

DNA METHYLATION; FEMALE; HUMAN PAPILLOMAVIRUS DNA TESTS; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; PRECANCEROUS CONDITIONS; PREDICTIVE VALUE OF TESTS; UTERINE CERVICAL NEOPLASMS;

EID: 84872838041     PISSN: 87551039     EISSN: 10970339     Source Type: Journal    
DOI: 10.1002/dc.21758     Document Type: Article

References (36)

1. Cannistra SA, Niloff JM,. Cancer of the uterine cervix. N Engl J Med 1996; 334: 1030-1038.
2. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 2002; 287: 2114-9.
3. Parkin DM,. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 3030-3044.
4. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J,. Virologic versus cytologic triage of women with equivocal Pap smears: A meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004; 96: 280-293.
5. Dehn D, Torkko KC, Shroyer KR,. Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma. Cancer 2007; 111: 1-14.
6. Feinberg AP, Tycko B,. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153.
7. Baylin SB, Herman JG,. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet 2000; 16: 168-174.
8. Lai HC, Lin YW, Huang TH, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123: 161-167.
9. Su HY, Lai HC, Lin YW, Chou YC, Liu CY, Yu MH,. An epigenetic marker panel for screening and prognostic prediction of ovarian cancer. Int J Cancer 2009; 124: 387-393.
10. McGaughran JM, Oates A, Donnai D, Read AP, Tassabehji M,. Mutations in PAX1 may be associated with Klippel-Feil syndrome. Eur J Hum Genet 2003; 11: 468-474.
11. Wallin J, Eibel H, Neubuser A, Wilting J, Koseki H, Balling R,. Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation. Development 1996; 122: 23-30.
12. Schnittger S, Rao VV, Deutsch U, Gruss P, Balling R, Hansmann I,. Pax1, a member of the paired box-containing class of developmental control genes, is mapped to human chromosome 20p11.2 by in situ hybridization (ISH and FISH). Genomics 1992; 14: 740-744.
13. Huang TH, Lai HC, Liu HW, Lin CJ, Wang KH, Ding DC, Chu TY,. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer. Int J Gynecol Cancer 2010; 20: 513-519.
14. Lai HC, Lin YW, Huang RL, et al. Quantitative DNA methylation analysis detects cervical intraepithelial neoplasms type 3 and worse. Cancer 2010; 116: 4266-4274.
15. Chu TY, Hwang KS, Yu MH, Lee HS, Lai HC, Liu JY,. A research-based tumor tissue bank of gynecologic oncology: characteristics of nucleic acids extracted from normal and tumor tissues from different sites. Int J Gynecol Cancer 2002; 12: 171-176.
16. Bergeron C, Fagnani F,. Performance of a new, liquid-based cervical screening technique in the clinical setting of a large French laboratory. Acta Cytol 2003; 47: 753-761.
17. Ogino S, Kawasaki T, Brahmandam M, et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006; 8: 209-217.
18. Coleman WB, Rivenbark AG,. Quantitative DNA methylation analysis: the promise of high-throughput epigenomic diagnostic testing in human neoplastic disease. J Mol Diagn 2006; 8: 152-156.
19. Etzioni R, Urban N, Ramsey S, et al. The case for early detection. Nat Rev Cancer 2003; 3: 243-252.
20. Apgar BS, Zoschnick L, Wright TC, Jr,. The 2001 Bethesda System terminology. Am Fam Physician 2003; 68: 1992-1998.
21. Smith AE, Sherman ME, Scott DR, et al. Review of the Bethesda System atlas does not improve reproducibility or accuracy in the classification of atypical squamous cells of undetermined significance smears. Cancer 2000; 90: 201-206.
22. Stoler MH, Schiffman M,. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 2001; 285: 1500-1505.
23. Silverloo I, Andrae B, Wilander E,. Value of high-risk HPV-DNA testing in the triage of ASCUS. Acta Obstet Gynecol Scand 2009; 88: 1006-1010.
24. Mei P, Liu YH, Li M, et al. Significance of high-risk human papillomavirus DNA in atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. Zhonghua Bing Li Xue Za Zhi 2009; 38: 337-339.
25. Nieh S, Chen SF, Chu TY, Lai HC, Lin YS, Fu E, Gau CH,. Is p16(INK4A) expression more useful than human papillomavirus test to determine the outcome of atypical squamous cells of undetermined significance-categorized Pap smear? A comparative analysis using abnormal cervical smears with follow-up biopsies. Gynecol Oncol 2005; 97: 35-40.
26. Eltoum IA, Chhieng DC, Crowe DR, Roberson J, Jin G, Broker TR,. Significance and possible causes of false-negative results of reflexhuman Papillomavirus infection testing. Cancer 2007; 111: 154-159.
27. Lorenzato M, Caudroy S, Nou JM, et al. Contribution of DNA ploidy image cytometry to the management of ASC cervical lesions. Cancer 2008; 114: 263-269.
28. Wentzensen N, Bergeron C, Cas F, Vinokurova S, von Knebel Doeberitz M,. Triage of women with ASCUS and LSIL cytology: use of qualitative assessment of p16INK4a positive cells to identify patients with high-grade cervical intraepithelial neoplasia. Cancer 2007; 111: 58-66.
29. Duncan L, Jacob S, Hubbard E,. Evaluation of p16INK4a as a diagnostic tool in the triage of Pap smears demonstrating atypical squamous cells of undetermined significance. Cancer 2008; 114: 34-48.
30. Lin CJ, Lai HC, Wang KH, et al. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results. Am J Obstet Gynecol 2010; 21: e1-e7
31. Lang D, Powell SK, Plummer RS, Young KP, Ruggeri BA,. PAX genes: Roles in development, pathophysiology, and cancer. Biochem Pharmacol 2007; 73: 1-14.
32. Muratovska A, Zhou C, He S, Goodyer P, Eccles MR,. Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival. Oncogene 2003; 22: 7989-7997.
33. Bernasconi M, Remppis A, Fredericks WJ, Rauscher FJ, III, Schafer BW,. Induction of apoptosis in rhabdomyosarcoma cells through down-regulation of PAX proteins. Proc Natl Acad Sci USA 1996; 93: 13164-13169.
34. Scholl FA, Kamarashev J, Murmann OV, Geertsen R, Dummer R, Schafer BW,. PAX3 is expressed in human melanomas and contributes to tumor cell survival. Cancer Res 2001; 61: 823-826.
35. He SJ, Stevens G, Braithwaite AW, Eccles MR,. Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity. Mol Cancer Ther 2005; 4: 996-1003.
36. Gnarra JR, Dressler GR,. Expression of Pax-2 in human renal cellcarcinoma and growth inhibition by antisense oligonucleotides. Cancer Res 1995; 55: 4092-4098.